AXT reports strong Q1 2026 with high Indium Phosphide demand; plans capacity expansion but stock seen overvalued.

AXT, Inc. posted strong Q1 2026 earnings driven by high demand for Indium Phosphide, with increased revenues, better profit margins, and a reduced net loss. The company plans to expand its Indium Phosphide production capacity over the next two years to meet growing demand. Despite the positive results, AXT's stock price has surged 7,000% in the past year, leading to concerns that it is now extremely overvalued. The analyst maintains a hold rating on the stock, suggesting caution for investors.